Burning Rock Biotech (BNR) Inventory (2019 - 2025)

Burning Rock Biotech's Inventory history runs 7 years deep, the most recent figure standing at $6.8 million for Q4 2025.

• In Q4 2025, Inventory fell 8.49% year-over-year to $6.8 million; the TTM figure through Dec 2025 stood at $6.8 million (down 8.49% YoY), while the FY2025 annual figure was $6.9 million, down 19.04% from the prior year.
• Inventory was $6.8 million for Q4 2025 at Burning Rock Biotech, down from $7.7 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $21.1 million in Q3 2022 to a low of $6.8 million in Q4 2025.
• Historically, Inventory has averaged $13.4 million across 5 years, with a median of $12.9 million in 2023.
• The sharpest annual moves came in 2021 and 2023: Inventory jumped 87.76% in 2021, then plunged 47.69% in 2023.
• A 5-year view of Inventory shows it stood at $19.3 million in 2021, then declined by 4.92% to $18.3 million in 2022, then plunged by 47.69% to $9.6 million in 2023, then declined by 21.92% to $7.5 million in 2024, then fell by 8.49% to $6.8 million in 2025.
• The last three Inventory figures came in at $6.8 million (Q4 2025), $7.7 million (Q3 2025), and $8.1 million (Q2 2025), per Business Quant data.